                               SEQUENCE LISTING

<110> MASSACHUSETTS INSTITUTE OF TECHNOLOGY
      WHITEHEAD INSTITUTE OF BIOMEDICAL RESEARCH
 
<120> SYNTHESIS OF COVALENT PROTEIN DIMERS THAT CAN INHIBIT MYC-DRIVEN 
      TRANSCRIPTION

<130> 730697: 083474-023PC

<140> PCT/US2022/033920
<141> 2022-06-17

<150> 63/213,024
<151> 2021-06-21

<160> 5     

<170> PatentIn version 3.5

<210> 1
<211> 84
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 1
Asn Val Lys Arg Arg Thr His Asn Val Leu Glu Arg Gln Arg Arg Asn 
1               5                   10                  15      


Glu Leu Lys Arg Ser Phe Phe Ala Leu Arg Asp Gln Ile Pro Glu Leu 
            20                  25                  30          


Glu Asn Asn Glu Lys Ala Pro Lys Val Val Ile Leu Lys Lys Ala Thr 
        35                  40                  45              


Ala Tyr Ile Leu Ser Val Gln Ala Glu Glu Gln Lys Leu Ile Ser Glu 
    50                  55                  60                  


Glu Asp Leu Leu Arg Lys Arg Arg Glu Gln Leu Lys His Lys Leu Glu 
65                  70                  75                  80  


Gln Leu Gly Gly 
                


<210> 2
<211> 82
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 2
Asp Lys Arg Ala His His Asn Ala Leu Glu Arg Lys Arg Arg Asp His 
1               5                   10                  15      


Ile Lys Asp Ser Phe His Ser Leu Arg Asp Ser Val Pro Ser Leu Gln 
            20                  25                  30          


Gly Glu Lys Ala Ser Arg Ala Gln Ile Leu Asp Lys Ala Thr Glu Tyr 
        35                  40                  45              


Ile Gln Tyr Met Arg Arg Lys Asn His Thr His Gln Gln Asp Ile Asp 
    50                  55                  60                  


Asp Leu Lys Arg Gln Asn Ala Leu Leu Glu Gln Gln Val Arg Ala Leu 
65                  70                  75                  80  


Gly Gly 
        


<210> 3
<211> 90
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 3
Met Ala Thr Glu Glu Asn Val Lys Arg Arg Thr His Asn Val Leu Glu 
1               5                   10                  15      


Arg Gln Arg Arg Asn Glu Leu Lys Arg Ser Phe Phe Ala Leu Arg Asp 
            20                  25                  30          


Gln Ile Pro Glu Leu Glu Asn Asn Glu Lys Ala Pro Lys Val Val Ile 
        35                  40                  45              


Leu Lys Lys Ala Thr Ala Tyr Ile Leu Ser Val Gln Ala Glu Thr Gln 
    50                  55                  60                  


Lys Leu Ile Ser Glu Ile Asp Leu Leu Arg Lys Gln Asn Glu Gln Leu 
65                  70                  75                  80  


Lys His Lys Leu Glu Gln Leu Arg Asn Ser 
                85                  90  


<210> 4
<211> 40
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (33)..(33)
<223> 6-aminohexanoic acid

<220>
<221> MOD_RES
<222> (38)..(38)
<223> 6-aminohexanoic acid

<400> 4
Gln Lys Lys Arg Lys Ser Lys Ala Asn Lys Lys Asn Trp Pro Lys Gly 
1               5                   10                  15      


Lys Leu Ser Ile His Ala Lys Asp Tyr Lys Gln Gly Pro Lys Ala Lys 
            20                  25                  30          


Xaa Arg Lys Gln Arg Xaa Arg Gly 
        35                  40  


<210> 5
<211> 22
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      probe

<400> 5
ccggctgaca cgtggtatta at                                                22


